Hamilton Lane Advisors LLC Crispr Therapeutics Ag Transaction History

Hamilton Lane Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 14, 2021	SELL	$110.2 - $156.64 $271,973 - $386,587	-2,468 Closed	0 $0
Q2 2021 Jul 20, 2021	BUY	$100.84 - $161.89 $248,873 - $399,544	2,468 New	2,468 $400,000
Q4 2020 Jan 13, 2021	SELL	$79.67 - $173.23 $799,647 - $1.74 Million	-10,037 Closed	0 $0
Q3 2020 Oct 15, 2020	BUY	$78.5 - $100.64 $787,904 - $1.01 Million	10,037 New	10,037 $839,000
Q4 2017 Jan 17, 2018	SELL	$16.95 - $23.48 $402,986 - $558,237	-23,775 Closed	0 $0
Q3 2017 Oct 16, 2017	BUY	$16.75 - $20.66 $398,231 - $491,191	23,775	23,775 $425,000

510

57.4M

1.74M

1.84M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.62B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Hamilton Lane Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Hamilton Lane Advisors LLC with notifications on news.